The increasing use of hemodialysis catheters: Evidence from the dopps on its significance and ways to reverse it

Seminars in Dialysis

Volumn 23, Issue 1, 2010, Pages 6-10

  Rayner, Hugh C ^a   Pisoni, Ronald L ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; HUMAN; INDWELLING CATHETER; INSTRUMENTATION; NOTE; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; STANDARD; TREATMENT OUTCOME; UTILIZATION REVIEW;

CATHETERS, INDWELLING; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 77950253420     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00675.x     Document Type: Note

References (40)

1. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009, 53(3):475-491.
2. Port FK, Pisoni RL, Bragg-Gresham JL, Satayathum SS, Young EW, Wolfe RA, Held PJ. DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States. Blood Purif 2004, 22(1):175-180.
3. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008, 23(10):3219-3226.
4. Spergel LM. Has the fistula first breakthrough initiative caused an increase in catheter prevalence? Semin Dial 2008, 21(6):550-552.
5. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int 2002, 61(1):305-316.
6. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK. Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003, 63(1):323-330.
7. Combe C, Pisoni RL, Port FK, Young EW, Canaud B, Mapes DL, Held PJ. Dialysis Outcomes and Practice Patterns Study: data on the use of central venous catheters in chronic hemodialysis. Nephrologie 2001, 22(8):379-384.
8. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998, 9(5):869-876.
9. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999, 55(3):1081-1090.
10. Jean G, Charra B, Chazot C, Vanel T, Terrat JC, Hurot JM, Laurent G. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 2002, 91(3):399-405.
11. Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild JP. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2000, 21(3):200-203.
12. Gulati S, Sahu KM, Avula S, Sharma RK, Ayyagiri A, Pandey CM. Role of vascular access as a risk factor for infections in hemodialysis. Ren Fail 2003, 25(6):967-973.
13. George A, Tokars JI, Clutterbuck EJ, Bamford KB, Pusey C, Holmes AH. Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study. BMJ 2006, 332(7555):1435.
14. Troidle L, Eisen T, Pacelli L, Finkelstein F. Complications associated with the development of bacteremia with Staphylococcus aureus. Hemodial Int 2007, 11(1):72-75.
15. Inrig JK, Reed SD, Szczech LA, Engemann JJ, Friedman JY, Corey GR, Schulman KA, Reller LB, Fowler VG. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin J Am Soc Nephrol 2006, 1(3):518-524.
16. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int 2005, 68(1):311-318.
17. Engemann JJ, Friedman JY, Reed SD, Griffiths RI, Szczech LA, Kaye KS, Stryjewski ME, Reller LB, Schulman KA, Corey GR, Fowler VG. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005, 26(6):534-539.
18. http://www.dh.gov.uk/en/Publichealth/Healthprotection/Healthcareacquiredinfection/Healthcareacquiredgeneralinformation/DH_063144, Available from:
19. Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, Mapes D, Krishnan M. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis 2009, 53(5):804-814.
20. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001, 60(4):1443-1451.
21. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002, 62(2):620-626.
22. Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003, 42(5):1013-1019.
23. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004, 15(2):477-486.
24. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005, 16(5):1449-1455.
25. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006, 47(3):469-477.
26. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death. QJM 2007, 100(7):415-422.
27. Moist LM, Trpeski L, Na Y, Lok CE. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008, 3(6):1726-1732.
28. Wasse H, Speckman RA, McClellan WM. Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial 2008, 21(5):483-489.
29. Wolfe R, Hulbert-Shearon T, Ashby VB, Messana JM. Decreases in catheter use are associated with decreases in mortality for dialysis facilities during 2000-03. J Am Soc Nephrol 2005, 16:95A.
30. Ravani P, Brunori G, Mandolfo S, Cancarini G, Imbasciati E, Marcelli D, Malberti F. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: a prospective multicenter study. J Am Soc Nephrol 2004, 15(1):204-209.
31. Mendelssohn DC, Ethier J, Elder SJ, Saran R, Port FK, Pisoni RL. Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II). Nephrol Dial Transplant 2006, 21(3):721-728.
32. Di Benedetto A, Basci A, Cesare S, Marcelli D, Ponce P, Richards N. Increased use of catheters as vascular access: is it justified by patients' clinical conditions? J Vasc Access 2007, 8(1):21-27.
33. Polkinghorne KR, Seneviratne M, Kerr PG. Effect of a vascular access nurse coordinator to reduce central venous catheter use in incident hemodialysis patients: a quality improvement report. Am J Kidney Dis 2009, 53(1):99-106.
34. Owen JE, Walker RJ, Edgell L, Collie J, Douglas L, Hewitson TD, Becker GJ. Implementation of a pre-dialysis clinical pathway for patients with chronic kidney disease. Int J Qual Health Care 2006, 18(2):145-151.
35. Asif A, Cherla G, Merrill D, Cipleu CD, Briones P, Pennell P. Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula. Kidney Int 2005, 67(6):2399-2406.
36. Saran R, Dykstra DM, Pisoni RL, Akiba T, Akizawa T, Canaud B, Chen K, Piera L, Saito A, Young EW. Timing of first cannulation and vascular access failure in haemodialysis: an analysis of practice patterns at dialysis facilities in the DOPPS. Nephrol Dial Transplant 2004, 19(9):2334-2340.
37. Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM, Pisoni RL. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg 2008, 247(5):885-891.
38. Young EW, Dykstra DM, Goodkin DA, Mapes DL, Wolfe RA, Held PJ. Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2002, 61(6):2266-2271.
39. Fissell R, Fuller D, Morgenstern H, Gillespie B, Mendelssohn D, Rayner H, Robinson B, Kawanishi H, Pisoni R. Hemodialysis patient preference for type of vascular access: predictors and variation across countries in the DOPPS. J Am Soc Nephrol 2009, abstract: in press
40. Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter access. Clin J Am Soc Nephrol 2009, 4(2):456-460.